Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : TGL WHAAAAAAAT! Alerts, thoughts, discussion. -- Ignore unavailable to you. Want to Upgrade?

To: asker2 who wrote (59683)	8/19/2000 3:40:27 AM
From: StocksDATsoar	Read Replies (1) \| Respond to of 150070

ragingbull.altavista.com DNAPrint Genomics (DNAP) used to be Catalyst Communications (CLYC) - both symbols are referenced here. Do some DD, call the company Now! There is great info for those willing. Recent WallStreetReporter interview: wallstreetreporter.com Some analysts are predicting that the genomics industry could ultimately be bigger than that of the Internet. redherring.com ragingbull.altavista.com Excellent DNAP POEM BY BBBabe? ragingbull.altavista.com Company Website: dnaprint.com Great News article that describes why this type of genomic research is the key. DNAPrint is one of a few labs actually doing this: doubletwist.com ragingbull.altavista.com The drug reaction/side effects problem is the genomics product that DNAPrint is targeting first. It is much bigger than what is described in the following article because most reactions are multiple gene related and DNAPrint is first (one of only three labs we know about) to do this. Whoever discovers the "multiple" gene combinations first (for each drug or disease) wins big in each "race". DNAPrint will use their combinatorial math platform and test other labs databases (those who do not know how to do the complex math) and they will share in the profits.: ragingbull.altavista.com Important posts (add more): ragingbull.altavista.com ragingbull.altavista.com ragingbull.altavista.com ragingbull.altavista.com ragingbull.altavista.com ragingbull.altavista.com ragingbull.altavista.com ragingbull.altavista.com E-Mail interview with Dr. Frudakis: ragingbull.altavista.com ragingbull.altavista.com ragingbull.altavista.com Info on O/S and Float: ragingbull.altavista.com Pink Sheet Leaders and Info: pinksheets.com Local Newspaper Article: newscoast.com Press Releases: dnaprint.com dnaprint.com dnaprint.com dnaprint.com dnaprint.com dnaprint.com dnaprint.com General Genomics Articles and Sites: ragingbull.altavista.com genomicsnews.com sciam.com genomics.phrma.org 209.52.56.28 cnn.com Investor Inquiries (Call the company Now!): DNAPrint Genomics, Sarasota Richard Craig Hall, 941/341-0136

To: asker2 who wrote (59683)	8/19/2000 9:35:40 AM
From: myturn	Read Replies (2) \| Respond to of 150070

Not me. I have not even been to the DNAP board on RB. I hardly post on RB. I am looking to phase out my posting all together. I feel like Thomas Allinder. I believe there are many shorts out there that follow us around. My strategy any more: If it is thinly traded stock, for example (VITC); I am not even going to talk about it on these threads to anyone till it is over 100% from where I bought it and I have taken my initial investment off of the table. Cheers RG